Sort
48,018 grants matching “immunotherapy”
Regulation of memory CD8 T cell development
$416,250Susan M Kaech · Yale University · R37 · FY2014 · AI
Fc receptor/Ig interactions and trafficking
$416,250Pamela J Bjorkman · California Institute Of Technology · R01 · FY2017 · AI
Engineering cellular immunotherapy to modulate immune responses in hemophilia
$416,250Valder R Arruda · Children'S Hosp Of Philadelphia · R01 · FY2018 · HL
Tissue-specific Borrelia Gene Expression
$416,250Erol Fikrig · Yale University · R37 · FY2015 · AI
Engineering cellular immunotherapy to modulate immune responses in hemophilia
$416,250Ben J Samelson-Jones · Children'S Hosp Of Philadelphia · R01 · FY2020 · HL
Regulation of memory CD8 T cell development
$416,250Susan M Kaech · Yale University · R37 · FY2017 · AI
Targeting TREM2 to boost anti-cancer therapy
$416,242Marco Colonna · Washington University · R01 · FY2021 · CA
Augmenting Antitumor Immunity
$416,194Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2013 · CA
REU Site: Molecular Basis of Cellular Phenotypes (MBCP) at The Wistar Institute
$416,116David Zuzga · Wistar Institute · · FY2023 · BIO
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCER
$416,112Robert David Schreiber · Washington University · T32 · FY2024 · CA
Boosting Oncolytic HSV Immunotherapy by Enabling Necroptosis
$416,040Hongyan Guo · Louisiana State Univ Hsc Shreveport · R21 · FY2025 · CA
Pathology Core
$416,024Xiaowei Xu · Wistar Institute · P01 · FY2022 · CA
Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic Leukemia
$416,011Xiaotu Ma · St. Jude Children'S Research Hospital · R01 · FY2025 · CA
Intestinal Cytokines in Cryptosporidiosis
$415,984Baylor College Of Medicine · R01 · FY2005 · AI
Collaborative Research: Integrative Adaptation of Dendrimer-peptide Conjugates for Cancer Immunotherapy
$415,969Seungpyo Hong · University Of Wisconsin-Madison · · FY2022 · MPS
Control of Airway Tolerance
$415,950Michael Croft · La Jolla Institute For Immunology · R01 · FY2013 · AI
Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
$415,924David Porter · University Of Pennsylvania · P01 · FY2021 · CA
An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes
$415,917Teresa P Dilorenzo · Albert Einstein College Of Medicine · R01 · FY2018 · DK
Core D: Long-term Follow-Up
$415,912Stephanie J Lee · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
COMPUTATIONAL TOOLS FOR THE ANALYSIS OF HIGH-THROUGHPUT IMMUNOGLOBULIN SEQUENCING EXPERIMENTS
$415,906Steven H. Kleinstein · Yale University · R01 · FY2022 · AI
TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTES
$415,800Terrence L Geiger · St. Jude Children'S Research Hospital · R01 · FY2010 · AI
Project 1: FLASH vs. Standard radiotherapy for treatment of PDAC and sparing normal intestine tissues
$415,788Constantinos Koumenis · University Of Pennsylvania · P01 · FY2025 · CA
Analytical tools for studying the tumor microenvironment leveraging spatial transcriptomics
$415,728Brooke L Fridley · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2022 · CA
HIFU-enhanced tumor vaccines
$415,691Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2012 · EB
EFFICACY/SAFETY OF MYCOPHENOLATE MOFETIL IMMUNOTHERAPY IN RHEUMATOID ARTHRITIS
$415,629Massachusetts General Hospital · M01 · FY2000 · RR